GlaxoSmithKline announces Vindi Banga to its Board as upcoming Independent Non-Executive Director

– UK, Brentford – GlaxoSmithKline announces that Manvinder Singh (Vindi) Banga will join the Board of the Company as a Non-Executive Director on 1 September 2015.

Mr Banga will succeed Sir Deryck Maughan as Senior Independent Director with effect from 5 May 2016. Sir Deryck will not seek re-election to the Company’s Board at the Company’s 2016 Annual General Meeting and will retire from the Board at the conclusion of the meeting.

Commenting on the appointment, Sir Philip Hampton, Chairman Designate, said “I am delighted that Vindi is joining the Board.

Vindi brings with him many years of experience and a track record of delivering outstanding performance in a highly competitive global consumer-focused industry which will be invaluable to GSK. My colleagues and I very much look forward to welcoming him to the Board.”

Mr Banga worked for Unilever plc from 1977 to 2010 in a number of senior positions. In his last role at Unilever, he was President of the Global Foods, Home & Personal Care businesses, as well as being member of the Unilever Executive Board. He is currently a partner at the private equity fund Clayton Dubilier & Rice and Chairman of the Supervisory Board of Mauser Group. He is also Senior Independent Director of Marks & Spencer Group plc and a Non Executive Director at Thomson Reuters Corporation.

The Company also announces the following changes to its Board Committees with effect from 8 May 2015:

  • Urs Rohner, Non-Executive Director, has been appointed Chairman of the Remuneration Committee in anticipation of Tom de Swaan’s retirement from the Company’s Board at the conclusion of today’s Annual General Meeting. Mr Rohner has been a member of the Remuneration Committee since his appointment to the Board on 1 January 2015.
  • Lynn Elsenhans, Non-Executive Director, has been appointed Chairman of the Corporate Responsibility Committee in anticipation of Sir Christopher Gent’s retirement from the Board at the conclusion of today’s Annual General Meeting. Ms Elsenhans has been a member of the Corporate Responsibility Committee since 1 October 2012.

GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>